Login
← Go Back
Syngene International
SYNGENE · Pharma > Pharmaceuticals & Drugs · Chairman: Kiran Mazumdar Shaw · MD: Jonathan Hunt · Listing date: Aug. 11, 2015 · Employees: 5437 · Bangalore · http://www.syngeneintl.com
Stock Price vs Company Growth
1d
0.4%
1w
0.3%
1m
13.5%
3m
10.8%
6m
24.9%
1y
9.0%
5y
12.4%
all
15.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 636 0.4%
599
761
Company Overview
Sales
3,642 Cr
Growth: 4.6%
Profit after Tax
464 Cr
Growth: -1.1%
Mid Cap
25,647 Cr
P/E: 51.6x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 3,642
Growth 4.6%
EBITDA 28.4%
P/S 7.0x
Dividend 0.2%
P/E 51.6x
Book Value ₹ 117
PEG Ratio 11.2x
ROE 10.3%
P/B 5.4x
Shareholding Pattern
Institutions
Government Pension Fund Global
1.14 %
Uti-Mid Cap Fund
1.03 %
Qualified Institutional Buyer
0.15 %
Promoters
Biocon Limited
70.1 %
Biocon Limited Employee Welfare Trust (Murali Krishnan K N And Amitava Saha)
0.32 %
Yamini R Mazumdar
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.
Belongs to (27 Indices) view more
Investors (435)
mahesh.g...
ajit.man...
goldman....
Followers (15)
yogesh
nitin2
keerthi